Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management?

In an interaction with India Pharma Outlook, Arushi Jain, Director at Akums Drugs & Pharmaceuticals Limited, discussed India’s growing nutraceutical sector, driven by rising health awareness and chronic diseases. She highlighted its integration with

Zydus Lifesciences Secures USFDA Approval for Generic Prostate Cancer Drug

Zydus Lifesciences Limited has established itself as a strong player in the world oncology market with its recent FDA approval to manufacture and sell a generic version of Apalutamide 60 mg tablets for the treatment of prostate cancer. The drug will

Surge in CKD Cases Sparks Call for Early Diagnosis and Better Care

Chronic Kidney Disease (CKD) is a growing public health crisis in India, affecting a significant percentage of the population and causing over 100,000 new cases of kidney failure annually. Despite its prevalence, early detection remains low, often le

CDSCO Declares 145 Drug Samples NSQ in February 2025 Testing Results

The Central Drugs Standard Control Organization (CDSCO) issued a report that, in February 2025, a total of 145 drug samples tested throughout India were found to be of a different quality standard. The increase in the NSQ reports is attributed...

Sanofi Healthcare Secures Marketing Authorization for Rezurock

Sanofi Healthcare India has received marketing authorization for Rezurock (belumosudil tablets) in India for the treatment of chronic Graft-versus-host disease (cGVHD) in patients aged 12 years and above.Rezurock is used globally for cGVHD pati...

Sun Pharma & Philogen Complete Enrollment for Phase III FIBROSARC Trial

Sun Pharmaceutical Industries Limited and Philogen S.p.A. have reported the successful conclusion of patient enrollment in the Phase III FIBROSARC trial for Soft Tissue Sarcoma (STS). All current Fibromun trials are progressing according to their...

Essential Pharma & Clinigen Expand JAPAC Partnership to Ensure Patient Access

Essential Pharma, a global specialty pharmaceutical organization dedicated to providing patients with access to low volume, clinically distinct niche pharmaceutical products in vital therapeutic fields, and Clinigen, the worldwide specialty...

Apogee Doses First Patient in Phase 2 APEX Trial for Atopic Dermatitis

Apogee Therapeutics, Inc., a biotechnology firm in the clinical stage, announced that the initial patient has received treatment in Part B of the phase 2 APEX clinical trial of APG777 for individuals with moderate-to-severe atopic dermatitis (AD)...

Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer

Ameera Shah’s Metropolis Healthcare Limited, the second-largest and most esteemed pathology laboratory chain in India, announced its partnership with Roche Diagnostics India and surrounding regions to launch the self-sampling human papillomavirus...

Tasso & ARUP Labs Unite to advance At-Home Blood Testing for Clinical Research

Tasso Inc., the premier provider of patient-focused, clinical-grade blood collection solutions, along with ARUP Laboratories, the largest nonprofit clinical and academic reference lab in the U.S., announced their partnership to create and...